weekly glp 1 agonist Glucagon-like peptide-1 receptor: mechanisms and advances in therapy GLP-1 receptor agonists and beyond.
Description
In an investigative report in partnership with KFF Health News, NBC News Anne Thompson reports on the growing cases of overdoses involving GLP-1 weight loss drugs.
The recently initiated large-sized FLOW trial investigating the effects of semaglutide on hard renal outcomes in patients with DKD will provide clarity whether GLP-1 receptor agonists may reduce the burden of DKD in addition to their other beneficial metabolic and cardiovascular effects.
Frequently asked questions
Once weekly subcutaneous injection, gradually titrated by your provider
Insulin []
